Halozyme Therapeutics
HALO
#1870
Rank
NZ$19.03 B
Marketcap
NZ$166.99
Share price
-1.82%
Change (1 day)
32.92%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): NZ$6.16

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is NZ$6.43. In 2025 the company made an earnings per share (EPS) of NZ$4.77 a decrease over its 2024 EPS that were of NZ$6.40.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.1629.08%
2025NZ$4.77-25.43%
2024NZ$6.40
2022NZ$2.71-48.07%
2021NZ$5.21196.87%
2020NZ$1.75-292%
2019NZ-$0.91-9.09%
2018NZ-$1.01-237.5%
2017NZ$0.73-149.38%
2016NZ-$1.48211.54%
2015NZ-$0.48-52.73%
2014NZ-$1.01-24.66%
2013NZ-$1.3348.98%
2012NZ-$0.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.30-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.47 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.62-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
NZ-$2.58-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ-$0.24-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA